Science Writer
at Technology Networks
Isabel holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age. Isabel was a Science Writer and Editor at Technology Networks until November 2025.
Education
Areas of Expertise
Got a Question for Isabel Ely, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Content Written By, Reviewed By, or Featuring Isabel Ely, PhD
Total: 123
Industry Insight
Cautious Optimism in a Year of Change: Insights From the 2025 Horizons Report
In a year defined by volatility and rapid transformation, the latest Horizons Report from CRB Group offers a revealing look at how life sciences organizations are navigating uncertainty while maintaining cautious optimism.
Article
How Is AI Shaping the Future of Automated Labs?
Experts shared their insights with Technology Networks, offering a glimpse into a future where automation and intelligence work hand in hand.
Article
How Is Collaboration Driving Life Science Innovation?
Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.
Industry Insight
Mapping Microglia To Unlock New Paths in Neuroscience
Dr. Najat Khan of Recursion shared insights into the creation of the Microglia Map and what it could mean for future drug discovery.
Industry Insight
Pushing the Boundaries of Long-Read Genomic Analysis
Dr. Joanne Mason discusses how Yourgene Health is advancing technologies that support long-read sequencing, reproductive health and accessible molecular diagnostics.
Industry Insight
Rethinking Pipette Design With Scientists in Mind
In this interview, Paul Withers from Eppendorf discusses the company’s latest addition to its pipetting lineup – the Research Pro Neo.
Industry Insight
Modernizing Microarrays for Faster, Scalable Genetic Discovery
To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.
Industry Insight
AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery
In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
Industry Insight
Mapping the South Korean Genome for Global Precision Medicine
Technology Networks spoke with Dr. Mark Van Oene, chief operating officer at PacBio, about an ambitious population genomics effort – the Korean Pangenome Reference Project.
Article
“Every patient has the potential to eradicate their cancer within their own immune system”: New Frontiers in Cancer Vaccines
Dr. Stephen Schoenberger, a professor at La Jolla Institute for Immunology, explores how recent discoveries and emerging tools are reshaping the field and what they could mean for the future of personalized cancer treatment.
Advertisement
